Description
Orforglipron is a small-molecule, non-peptide agonist of the glucagon-like peptide-1 (GLP-1) receptor, notable as an orally available compound in this class. This capsule presents it in an oral solid-dose research format.
Non-clinical studies in cell and animal models have examined GLP-1 receptor signaling, glucose handling, and appetite-related endpoints. Its oral, small-molecule nature makes it a useful contrast to peptide-based GLP-1 agonists in research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.